A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges' https://t.co/wyedwUYhSh
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2024 – Apr 2025Where it's discussed
-
X / Twitter28 posts
-
News10 articles
-
Blogs3 articles
-
YouTube2 videos
-
Bluesky1 posts
AI synopsis
What people are saying
Several discussions express curiosity about the therapeutic potential of psychedelics for addiction, with users highlighting the need for more clinical research. For instance, one post mentions a 'recent review article' discussing substances like psilocybin and LSD, indicating a focus on scientific exploration. The tone ranges from interest to cautious optimism, emphasizing the significance of safety and limitations discussed in the publication, which underscores the article's role in shaping future research directions.
Most discussions recognize the importance of exploring psychedelics for addiction, with some emphasizing the potential benefits highlighted in the publication.
The posts reflect high curiosity, especially around safety, efficacy, and ongoing research, indicated by phrases like 'interested in this topic' and noting the article's relevance.
Many comments reference specific aspects of the publication, such as safety concerns and the need for further research, showing moderate but thoughtful engagement.
The discussions seem to view the review as potentially influential in shaping future research or treatment approaches, though there is a cautious tone.
Abstract in brief
- Mental health and substance use disorders (SUDs) are significant contributors to global health issues, prompting exploration into the use of psychedelics as potential treatments.
- This review evaluates the clinical evidence, therapeutic potential, and safety of various psychedelics such as psilocybin, LSD, ketamine, MDMA, and ibogaine specifically for SUDs.
- The authors emphasize the necessity for further clinical research to better understand the benefits and risks of psychedelics in treating SUDs, noting existing limitations and challenges in the field.
Top posts
Most liked on X and BlueskyCurrent Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges https://t.co/hAZdV1hzA8
Current Perspectives ontheClinical Research andMedicalization ofPsychedelic Drugs forAddiction Treatments: Safety, Efficacy, Limitations andChallenges (full text link) https://t.co/iJ9pMNzBKA
Nuestro último artículo científico sobre psicodélicos para el tratamiento de adicciones publicado en @SpringerNature esta disponible gratis en https://t.co/k2BMFzKopP https://t.co/Mbba5BBFYC
New paper on Psychedelics for Addiction Treatment published on https://t.co/rfWFQJQIl8 is available for free at Springer Nature
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges https://t.co/32ZhU6rt9L https://t.co/Gl2YBb86Fy
All mentions
Therapeutic Potential of Psychedelics in Mental Health Treatment
Recent scientific studies suggest some psychedelics like LSD, psilocybin, and MDMA may be effective for treating mental health issues such as addiction, depression, and PTSD. We explore their origins, effects on the…
Therapeutic Potential of Psychedelics for Addiction Treatment
This presentation by Antonio Gómez Escolar discusses the clinical research, safety, efficacy, limitations, and future challenges of using psychedelics like psilocybin, LSD, ketamine, MDMA, and ibogaine for treating…
youtu.be/vSa_Fv9GimU?...
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
RT @Peter_Grinspoon: A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research…
A subject I'm particularly interested in: #Psychedelics for #ADDICTION 'Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges' https://t.co/wyedwUYhSh
https://t.co/uJOhH3QIIc A recent review article gives an overview of many psychedelic substances, including psilocybin, and highlights common concerns in the research field. PsyPal hopes to start filling this research gap for individuals with end-of-life distress.
RT @BellevueDoc: Current Perspectives ontheClinical Research andMedicalization ofPsychedelic Drugs forAddiction Treatments: Safety, Ef…
Current Perspectives ontheClinical Research andMedicalization ofPsychedelic Drugs forAddiction Treatments: Safety, Efficacy, Limitations andChallenges (full text link) https://t.co/iJ9pMNzBKA
New paper on Psychedelics for Addiction Treatment published on https://t.co/rfWFQJQIl8 is available for free at Springer Nature
RT @AntonGomezES: Nuestro último artículo científico sobre psicodélicos para el tratamiento de adicciones publicado en @SpringerNature esta…
RT @AntonGomezES: Nuestro último artículo científico sobre psicodélicos para el tratamiento de adicciones publicado en @SpringerNature esta…
RT @AntonGomezES: Nuestro último artículo científico sobre psicodélicos para el tratamiento de adicciones publicado en @SpringerNature esta…
Nuestro último artículo científico sobre psicodélicos para el tratamiento de adicciones publicado en @SpringerNature esta disponible gratis en https://t.co/k2BMFzKopP https://t.co/Mbba5BBFYC
RT @BellevueDoc: Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Ef…
RT @BellevueDoc: Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Ef…
RT @BellevueDoc: Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Ef…
@zinjanthopus https://t.co/HadJVs96uh
RT @BellevueDoc: Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Ef…
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges https://t.co/hAZdV1hzA8
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges https://t.co/32ZhU6rt9L https://t.co/Gl2YBb86Fy